Posted On: 09/10/2016 6:46:26 PM
Post# of 99177
$PIP recovery climb $2.66
Amex
Website
Low Float
Shares Outstanding 65.59M
Float 55.29M
% Held by Insiders 2.44%
% Held by Institutions 11.90%
Shares Short 2.44M
Short Ratio 14.84
Short % of Float 4.48%
Shares Short (prior month) 2.62M
Headlines
and Filings
PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccines based on DepoVax, a proprietary technology platform that contributes recombinant protective antigen bulk drug substance. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The company has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax vaccine platform to develop an anthrax vaccine. PharmAthene, Inc. is headquartered in Annapolis, Maryland.
Amex
Website
Low Float
Shares Outstanding 65.59M
Float 55.29M
% Held by Insiders 2.44%
% Held by Institutions 11.90%
Shares Short 2.44M
Short Ratio 14.84
Short % of Float 4.48%
Shares Short (prior month) 2.62M
Headlines
and Filings
PharmAthene, Inc., a biodefense company, develops and commercializes medical counter measures against biological and chemical threats in the United States. The company focuses on developing lyophilized anthrax vaccines based on DepoVax, a proprietary technology platform that contributes recombinant protective antigen bulk drug substance. It serves National Institute of Allergy and Infectious Diseases, and the Biomedical Advanced Research and Development Authority. The company has a license agreement with ImmunoVaccine Technologies for the use of the DepoVax vaccine platform to develop an anthrax vaccine. PharmAthene, Inc. is headquartered in Annapolis, Maryland.
(0)
(0)
